Boston Scientific Corporation (BSX)
CPC Advisors LLC Sells 27,747 Shares of Boston Scientific Corporation $BSX
CPC Advisors LLC lowered its holdings in Boston Scientific Corporation (NYSE: BSX) by 54.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,851 shares of the medical equipment provider's stock after selling 27,747 shares during the
Top Wall Street Forecasters Revamp Boston Scientific Expectations Ahead Of Q1 Earnings
Boston Scientific Corporation (NYSE:BSX) will release earnings for its first quarter before the opening bell on Wednesday, April 22.
Wall Street Refuses to Blink: 2 Healthcare Stocks at 52-Week Lows That Analysts Still Love
Boston Scientific (NYSE: BSX) trades around $61, with analyst price targets ranging from $69 (conservative) to $124 (optimistic), implying substantial upside.
Will Robust Cardiovascular Performance Fuel BSX's Q1 Earnings?
Boston Scientific heads into Q1 earnings with strong Cardiovascular momentum and steady MedSurg growth, as estimates point to solid revenue and earnings gains.
Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2026.
Boston Scientific (BSX) Outperforms Broader Market: What You Need to Know
Boston Scientific (BSX) closed the most recent trading day at $64.61, moving +1.24% from the previous trading session.
Boston Scientific (BSX) Earnings Expected to Grow: Should You Buy?
Boston Scientific (BSX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report?
Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Boston Scientific (BSX) Stock Slides as Market Rises: Facts to Know Before You Trade
Boston Scientific (BSX) closed at $61.28 in the latest trading session, marking a -2.05% move from the prior day.
Boston Scientific (BSX) Stock Sinks As Market Gains: Here's Why
In the most recent trading session, Boston Scientific (BSX) closed at $61.86, indicating a -1.17% shift from the previous trading day.
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Boston Scientific: From Hypergrowth To Durable Compounding
Boston Scientific has declined over 35% in six months, yet maintains double-digit growth and 28% operating margins, creating a compelling buy opportunity. BSX trades at mid-tier valuations, despite a 5-year revenue CAGR of 15.1% and EBITDA CAGR of 19%, outpacing Medtronic and Edwards Lifesciences. Growth drivers include electrophysiology, the WATCHMAN CHAMPION trial, and M&A, with the potential to expand the addressable market and sustain 11% EPS growth.
